PPARG and type 2 diabetes mellitus: Another study involved inducing type 2 diabetes in rats using STZ and nicotinamide, followed by an 8-week treatment with hesperidin (100 mg/kg/day) alone or in combination with omeprazole or GW9662, which acts as an antagonist for peroxisome proliferator-activated receptor-γ (PPAR-γ).